RECENT ADVANCES OF CHOLINESTERASE INHIBITORS PLAYING A CRITICAL ROLE IN THE TREATMENT OF ALZHEIMER’S DISEASE (2020-2022)
Alzheimer’s disease (AD) is a common neurodegenerative disorder which has a catastrophic effect on the brain. It significantly affects people’s daily life, especially the population over the age of 65, with problems such as neuron death, memory loss, cognitive disorders, and cholinergic dysfunction....
Saved in:
| Main Authors: | Elmas Rumeysa Yıldırım, Nuray Ulusoy Güzeldemirci |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Istanbul University Press
2023-06-01
|
| Series: | Sabiad |
| Subjects: | |
| Online Access: | https://cdn.istanbul.edu.tr/file/JTA6CLJ8T5/1B853B8CEB1E4A709101150DF508BF13 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Design and evaluation of substituted cinnamoyl piperidinyl acetate derivatives as potent cholinesterase inhibitors
by: Maryam Esmkhani, et al.
Published: (2025-06-01) -
Trends and disparities in the use of cholinesterase inhibitors to treat Alzheimer’s disease dispensed by the Brazilian public health system – 2008 to 2014: a nation-wide analysis
by: Flávia Silva de Moraes, et al. -
Assessment of Potential Acetylcholinesterase Inhibitors: An In Silico Study
by: Nathaniel Ohiemi Amedu, et al.
Published: (2024-08-01) -
Can Marine Products Improve Alzheimer’s Disease
by: Hamid-Reza Adhami, et al.
Published: (2020-11-01) -
Synthesis, Biological Evaluation, and In Silico Characterization of Novel Imidazothiadiazole–Chalcone Hybrids as Multi-Target Enzyme Inhibitors
by: Hakan Alici, et al.
Published: (2025-06-01)